109 related articles for article (PubMed ID: 5606081)
21. Some biological characteristics of the mouse ascitic tumour NK-Ly passaged in AB-Jena-Gat.-Ko. strain mice.
Seidlová A
Neoplasma; 1969; 16(4):409-16. PubMed ID: 5344227
[No Abstract] [Full Text] [Related]
22. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
Olinescu A; Hristescu S; Mazilu E
Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
[TBL] [Abstract][Full Text] [Related]
23. Effect of sodium-copper-chlorophyllin as a complement inhibitor on the allograft reaction.
Fujii G; Suzuki M; Hirose Y; Goto S; Ishibashi Y; Haga K; Sindo T
Jpn J Exp Med; 1966 Oct; 36(5):498-507. PubMed ID: 5339391
[No Abstract] [Full Text] [Related]
24. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
Belokhvostov AS; Grikurova NK
Vopr Onkol; 1981; 27(12):56-9. PubMed ID: 7324403
[TBL] [Abstract][Full Text] [Related]
25. [On a simple method of "immunization" against cancer].
Schmidt F
Krebsarzt; 1965; 20(4):242-7. PubMed ID: 5848063
[No Abstract] [Full Text] [Related]
26. [Experimentally acquired resistance to tumor transplantation and the rejection of homologous skin transplantation in mice].
Enoki Y
Igaku To Seibutsugaku; 1967 Mar; 74(3):185-6. PubMed ID: 4861830
[No Abstract] [Full Text] [Related]
27. Globulin coating in vivo of Ehrlich's ascites carcinoma cells.
Thunold S
Transplantation; 1968 Aug; 6(5):716-27. PubMed ID: 4179287
[No Abstract] [Full Text] [Related]
28. [Experimental contribution to the analysis of the immunological reactions of ocular structures in presence of heterologous tumors. (a). Mouse ascites tumor graft in the rabbit cornea. (b). Mouse ascites tumor wrapped in autoplastic membrane grafted in the anterior chamber of the guinea pig eye].
Claudio C; Corrado F
Riv Anat Patol Oncol; 1969; 35():292-309. PubMed ID: 5404378
[No Abstract] [Full Text] [Related]
29. A study on transplantation immunity of Ehrlich ascites tumor and methylcholanthrene-induced tumor in mice, with special reference to local immunity of lymph nodes draining the site of sensitization.
Kitano M; Okada Y
Bull Chest Dis Res Inst Kyoto Univ; 1968 Mar; 1(1):1-17. PubMed ID: 5678190
[No Abstract] [Full Text] [Related]
30. [Establishment of immunity against transplantation tumor by administration of gelatin and its derivatives in mice].
Enoki Y
Igaku To Seibutsugaku; 1971 Feb; 82(2):81-3. PubMed ID: 5165290
[No Abstract] [Full Text] [Related]
31. Hematologic changes in rats inoculated intraperitoneally with Ehrlich ascites carcinoma.
Dabrowska B; Janik P; Radwański Z; Dux K
Arch Immunol Ther Exp (Warsz); 1966; 14(6):724-9. PubMed ID: 5957994
[No Abstract] [Full Text] [Related]
32. [Changes in the immunobiologic properties of Ehrlich ascites carcinoma under the effect of suspension from normal rat tissues. I. Heterotransplantation of Ehrlich ascites carcinoma].
Novikov DK
Tsitologiia; 1965; 7(3):420-3. PubMed ID: 5879870
[No Abstract] [Full Text] [Related]
33. [The role of serum humoral factors in metastasis and recurrence of Ehrlich carcinoma in mice].
Donenko FV; Sitdikova SM; Moroz LV
Biull Eksp Biol Med; 1997 Oct; 124(10):443-5. PubMed ID: 9410180
[No Abstract] [Full Text] [Related]
34. [Tolerance induction by passage of the antigen with tumor cells].
Bundschuh G
Radiobiol Radiother (Berl); 1983; 24(4):525-30. PubMed ID: 6647799
[No Abstract] [Full Text] [Related]
35. Factors influencing skin graft survival from donors with Ehrlich ascites tumor.
Biran S; Ben-Hur N; Robinson E
Oncology; 1970; 24(5):344-8. PubMed ID: 4922595
[No Abstract] [Full Text] [Related]
36. [Immunoglobulins from a tumor-bearing body as possible regulators of the growth rate of relapses and metastases of Ehrlich carcinoma].
Donenko FV; Moroz LV
Biull Eksp Biol Med; 1995 Jan; 119(1):62-4. PubMed ID: 7718807
[No Abstract] [Full Text] [Related]
37. Selective inhibition of the secondary immune response to mouse skin allografts by cell-free Ehrlich ascites carcinoma fluid.
McCarthy RE; Coffin JM; Gates SL
Transplantation; 1968 Aug; 6(5):737-43. PubMed ID: 4884862
[No Abstract] [Full Text] [Related]
38. [Natural resistance and induced resistance to ATPC + tumor in mice].
Marconi P; Pitzurra M; Bistoni F; Iorio A
Boll Ist Sieroter Milan; 1972; 51(1):27-43. PubMed ID: 5083003
[No Abstract] [Full Text] [Related]
39. [Antineoplastic immunological reactions in animals with Ehrlich's carcinoma].
Bergamini G; D'Acunzo L; Fazio G; Giudici G
Riv Patol Clin Sper; 1967; 8(4):477-88. PubMed ID: 5605966
[No Abstract] [Full Text] [Related]
40. Influence of immunosuppressive pretreatment on the survival of mice challenged with Ehrlich ascites carcinoma (EAC).
Jakóbisiak M; Lasek W; Kańtoch M; Rozmysłowicz T
Neoplasma; 1980; 27(2):147-50. PubMed ID: 7393355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
